Perhaps you think it's impossible to score another 1,000% gain off this "tech titan" stock. Think again. An unusual strategy lets you virtually "recreate" gains off the biggest companies you thought had come and gone. CLICK HERE to see how it works.
Financials Surge After Paulson Buys
by The Investment U Research Team
After positive comments by the Federal Reserve and Ben Bernanke, Wall Street marched even higher yesterday before profit taking set in, blunting some of those gains. What made news in the aftermarket was John Paulson’s second quarter holdings statement.
It showed that Paulson & Co. had loaded up on Bank of America (NYSE: BAC) – buying 168 million shares valued at $2.2 billion – and other financial stocks like Goldman Sachs (NYSE: GS) and Marshall & Ilsley (NYSE: MI)
Making this disclosure more interesting is that fact that John Paulson was famously bearish for 2008 and reported to make more than $2.5 billion from his stance. These are huge bullish bets that the markets are taking notice of.
Last night and this morning during after hours trading the tickers for most of the financial sector came alive and more than a few companies added a point or two. It is expected that this trend should continue into today as the Street digests this data.
However, in all of the excitement, it seems to have pulled attention away from the larger question of whether the market has overextended itself over the past few months. The short answer seems to be no.
But – and there’s always a but – the farther and faster the market races upwards the louder and more convincing a pullback becomes. Perhaps making one inevitable.
Another thing to remember, is that Paulson owned these at the end of the second quarter (June 30), and he could have liquidated much of these holdings – or could be in the process of doing so now.
Symbols mentioned in this article: BAC, GS and MI.
- Bank Pullback Exposes Casino Opportunities
- Bailout Report Card – The Results Might Surprise You
- Take Profits on Gold: The Media’s Dead Wrong About This Market
|
The Company Set to Dominate a $60 Billion-a-Year Market
$60 billion is spent on cancer treatment in the U.S. - each year. And one company is poised to receive the lion's share of it.
The medical director at the Alta Bates Comprehensive Cancer Center says, "...possibly a third of our cancer patient population will soon be undergoing this [company's] treatment."
Another doctor at the University of Texas MD Anderson Cancer Center says he intends to treat over 1,000 patients a year with this technology.
Here's how you can claim your stake in the company before this cash infusion sends shares soaring.
Comments
**By submitting your comment you agree to adhere to our Comment Policy and Privacy Policy.Check out our selection of daily Investment Research:
 |
 |
Investment U RSS Feed